(founded in 2004, 100 employees) specialized in rapid tests, Elisa and homogenous enzyme immune assays in the fields of gynaecology, infectious diseases, cardiac infarct markers, detection of cancer, urology and especially drug of abuse.
(founded in 2001, 2 employees) develops novel pharmaceuticals for diseases like Parkinson's, Alzheimer's, schizophrenia and depression by using innovative neuronal targets (disease-related genes or proteins).
(in the BioPark, founded in 2004, 48 employees) develops and markets integrated test systems for human diagnostics. The fully automated numares systems provide information about formation, extent and severity of diseases in high throughput operations. They ensure improved treatment options at high patient safety and cost-effectiveness.